ClinicalTrials.Veeva

Menu

Inhibitory Receptors in Eosinophils of Atopic Subjects

Clalit Health Services logo

Clalit Health Services

Status

Completed

Conditions

Atopic Dermatitis
Food Allergy
Asthma
Atopy
Allergic Rhinitis

Study type

Observational

Funder types

Other

Identifiers

NCT01489293
MMC110053CTIL

Details and patient eligibility

About

The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.

Enrollment

40 patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 20-60 years
  • a physician-diagnosed atopic disease

Exclusion criteria

  • atopic disease not active
  • steroid treatment
  • active non-atopic inflammatory disease, including infections
  • pregnancy

Trial design

40 participants in 2 patient groups

atopic subjects
Description:
Patients with one atopic disease or more (atopic dermatitis,rhinitis, asthma, food allergy)
non-atopic subjects
Description:
Control group without atopic diseases.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems